logo
The age-reversing routine of this 56-year-old woman is beating million-dollar biohacks by a wide margin- here's what she does

The age-reversing routine of this 56-year-old woman is beating million-dollar biohacks by a wide margin- here's what she does

Time of India2 days ago

Julie Clark
is turning heads online with a simple, $4-a-day
age-reversing routine
. She is 56 years old, but her biological age is only 36. She is now the second oldest person in the world. Her method is natural, useful, and much cheaper than high-tech methods.
One of the most successful and well-liked individuals attempting the $2 million a year process is American millionaire and entrepreneur Bryan Johnson.
Bryan Johnson
will most probably be envious of this woman's habit of reversing her age.
Her way of life includes getting up early, working out in a balanced way, eating clean, taking few supplements, and sticking to strict sleep schedules. This is a realistic and effective alternative to million-dollar longevity programs like Bryan Johnson's.
This strategy provides a less complicated and more affordable option to exorbitantly priced
biohacking
techniques.
ALSO READ:
Jonathan Joss, voice of John Redcorn from King of the Hill, tragically shot and killed at 59
Live Events
Best-selling author and health researcher Craig Brockie recently shared information about Julie Clark, a 56-year-old woman whose biological age is 36, on X.
According to Brockie, Clark was surpassing Bryan Johnson and placing second on the global longevity board, redefining the science of aging.
Why is she being compared to Bryan Johnson?
For far too long, Bryan Johnson has been the well-known spokesperson for
reverse aging
. But his regimen, known as the Blueprint, consists of a strict vegan diet, numerous supplements, intense exercise, and other procedures that cost an estimated $2 million a year.
A shining alternative in this case is Clark's reverse aging regimen, which is easy to follow, inexpensive, and simple, and produces surprisingly good results.
What does the term "reverse ageing" mean?
Age reversal, or reverse ageing, slows the body's natural aging process and physiological changes.
Scientists are investigating cellular and molecular interventions to reverse age-related changes, but total reversal is still impossible. Lifestyle changes and treatments have been used to target biological age, which is health and system function.
What does her daily routine look like?
Brockie shared Clark's
anti-aging regimen
for optimal health and long-term longevity.
Julie Clark's health routine:
Morning Routine:
• Wakes up between 4-5 AM, makes bed, drinks green tea, and engages in calming activities.
• Goes to the gym on weekends for body and mind relaxation.
Movement:
• Trains six days a week, focusing on lifting and cardio.
• Uses compound movements like Romanian deadlifts and split squats.
• Focuses on Zone 2 training during cardio.
• Ends workouts with a 20-30 minute sauna and a 5-minute cold shower.
Diet:
• Tracks food intake, aiming for 1 lb of vegetables, half of which are greens, and 100g of protein.
• Breakfast includes moringa, fermented greens, collagen, maca, lunch includes veggies with eggs or meat, and dinner includes steak, greens, or sardines.
Supplements:
• Takes pills of B-complex, fish oil, probiotics, Magnesium, Vitamin D3 + K2, Inositol, Apigenin & L-theanine.
Sleep Schedule:
• Bedtime is 8, and sleep is 8:30.
• Prior to sleep, she takes a long walk with calming music.
FAQs
How much does Julie Clark's anti-aging regimen cost?
Only about $4 per day, significantly less than high-end biohacking programs.
What's Julie Clark's secret for looking younger?
She attributes her success to regular sleep, exercise, a healthy diet, and mindfulness, all of which are inexpensive treatments.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bryan Johnson claims he has the biology of a 10-year-old—thanks to oxygen therapy. Can science really turn back time?
Bryan Johnson claims he has the biology of a 10-year-old—thanks to oxygen therapy. Can science really turn back time?

Time of India

timean hour ago

  • Time of India

Bryan Johnson claims he has the biology of a 10-year-old—thanks to oxygen therapy. Can science really turn back time?

Imagine waking up with the energy levels, organ functions, and biological markers of a 10-year-old at 46. That's exactly what tech entrepreneur and self-proclaimed biohacker Bryan Johnson claims he has achieved, and he credits it to a radical experiment: 90 days of intense oxygen therapy. Johnson, known for spending millions annually on anti-aging regimens under his Blueprint project, recently announced that this latest venture has helped him 'reverse' aspects of his biological age to that of a pre-teen. His claims, though bold, are grounded in an evolving field of science where longevity research is beginning to intersect with what was once considered science fiction. What is oxygen therapy? The treatment at the center of Johnson's latest experiment is hyperbaric oxygen therapy (HBOT). While oxygen therapy in general refers to the medical use of supplemental oxygen, HBOT involves breathing pure oxygen in a pressurized chamber. These chambers are typically pressurized at two to three times normal atmospheric levels, enabling oxygen to dissolve more effectively into the bloodstream and reach tissues that may be oxygen-starved. This isn't a new practice. HBOT has been FDA-approved for a range of medical conditions, including carbon monoxide poisoning, gangrene, non-healing wounds, and decompression sickness (common among divers). by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Una inversión en Amazon podría darte un salario extra. Undo But over the last few years, HBOT has gained attention for its potential anti-aging and regenerative benefits. How does HBOT work on the body? Under normal conditions, oxygen is carried mostly by red blood cells. But when the body is exposed to high-pressure pure oxygen, more oxygen dissolves directly into the blood plasma. This super-oxygenated blood can then travel deeper into body tissues, promoting healing and rejuvenation at the cellular level. Some of the key reported benefits of HBOT include: Increased production of stem cells, which help regenerate damaged tissues Reduced inflammation across various organs Improved mitochondrial function, which boosts cellular energy Enhanced cognitive performance Potential telomere extension – telomeres are protective caps on DNA that shorten with age A 2020 study conducted in Israel found that HBOT could not only increase the length of telomeres (often considered a marker of youthfulness) but also reduce senescent cells, which are old, malfunctioning cells that contribute to aging and disease. Bryan Johnson's results: Hype or hope? According to Johnson, after 90 days of HBOT combined with his usual strict regimen of exercise, plant-based diets, sleep optimization, and regular medical testing, he experienced: Improvements in skin health Reduction in biological markers of aging Enhanced lung capacity and cardiovascular performance Better cognitive function and sleep quality He claims that his overall biological profile, assessed using various biomarkers, now resembles that of a 10-year-old. It's important to note, however, that biological age can be calculated differently depending on the metrics used, and it's not a universally agreed-upon standard. Is it safe and effective for everyone? While Johnson's transformation has captured the public's imagination, medical experts urge caution. HBOT, though promising, is not without risks. Prolonged exposure can lead to oxygen toxicity, barotrauma (injury caused by pressure), and even vision changes. Moreover, the accessibility of such treatments remains limited. A full course of HBOT can cost thousands of dollars, and the kind of monitoring and medical supervision Johnson undergoes is far from standard. Dr. Shai Efrati, a pioneer in HBOT research, argues that with the right protocols and patient selection, HBOT could one day be used more broadly to slow biological aging, but more peer-reviewed studies are needed before it can be widely recommended. A glimpse into the future? Bryan Johnson's experiment opens up exciting, if controversial, possibilities in the field of anti-aging and longevity science. It challenges traditional views of aging as a linear, irreversible process and suggests that, with the right tools, we might not only delay aging but potentially rewind certain biological clocks. Still, it's essential to separate anecdotal success stories from scientific consensus. As fascinating as Johnson's story is, it should serve as a launchpad for deeper inquiry, not a universal prescription. While the idea of having the biology of a 10-year-old at midlife sounds like a dream, the reality is far more nuanced. Oxygen therapy, particularly HBOT, holds promise, but it's not a miracle solution, at least not yet. What Bryan Johnson's journey does offer, however, is a compelling glimpse into the future of how we might age and perhaps, how we might not. One step to a healthier you—join Times Health+ Yoga and feel the change

'Direct Threat': Chinese Couple Caught Smuggling 'Agroterrorism Agent' Into US
'Direct Threat': Chinese Couple Caught Smuggling 'Agroterrorism Agent' Into US

News18

time13 hours ago

  • News18

'Direct Threat': Chinese Couple Caught Smuggling 'Agroterrorism Agent' Into US

Last Updated: The FBI Director's concern came after two Chinese nationals were arrested for smuggling a "biological pathogen" that can be used as an agricultural terrorism weapon into the US. FBI Director Kash Patel on Wednesday warned against a 'serious national security threat" after two Chinese nationals were arrested in the US for allegedly smuggling a 'dangerous biological pathogen" into the country to study at the University of Michigan laboratory. The FBI Director's concern came after two Chinese nationals were arrested for smuggling a dangerous 'biological pathogen" that had the potential to be used as an agricultural terrorism weapon into the United States for research. 'This case is a sobering reminder that the Chinese Communist Party continues to deploy operatives and researchers to infiltrate our institutions and target our food supply, an act that could cripple our economy and endanger American lives," Patel was quoted as saying by Fox News. 'Smuggling a known agroterrorism agent into the U.S. is not just a violation of law, it's a direct threat to national security. I commend the FBI Detroit Division and our partners at CBP for stopping this biological threat before it could do real damage," he added. Chinese Nationals Charged With Smuggling 'Agroterrorism Agent' Into US The US Department of Justice on Tuesday identified the pathogen as Fusarium graminearum, a fungus, classified in scientific literature as a potential 'agroterrorism weapon'. In a statement, it said that the fungus causes 'head blight" in some crops and is responsible for billions of dollars in economic losses globally each year. According to an FBI criminal complaint, Zunyong Liu, 34, a researcher currently in China, brought the fungus into the United States while visiting his girlfriend, Yunqing Jian, 33, in July 2024. He admitted to smuggling in the fungus so he could conduct research on it at a University of Michigan laboratory where his girlfriend worked, according to the complaint. Both individuals have been charged with conspiracy, smuggling goods into the United States, false statements, and visa fraud. Watch India Pakistan Breaking News on CNN-News18. Get breaking news, in-depth analysis, and expert perspectives on everything from geopolitics to diplomacy and global trends. Stay informed with the latest world news only on News18. Download the News18 App to stay updated! First Published: June 04, 2025, 09:01 IST

US scientists warn that trump's cuts will set off a brain drain
US scientists warn that trump's cuts will set off a brain drain

Business Standard

time21 hours ago

  • Business Standard

US scientists warn that trump's cuts will set off a brain drain

Ardem Patapoutian's story is not just the American dream, it is the dream of American science. He arrived in Los Angeles in 1986 at age 18 after fleeing war-torn Lebanon. He spent a year writing for an Armenian newspaper and delivering Domino's at night to become eligible for the University of California, where he earned his undergraduate degree and a postdoctoral fellowship in neuroscience. He started a lab at Scripps Research in San Diego with a grant from the National Institutes of Health, discovered the way humans sense touch, and in 2021 won the Nobel Prize. But with the Trump administration slashing spending on science, Dr. Patapoutian's federal grant to develop new approaches to treating pain has been frozen. In late February, he posted on Bluesky that such cuts would damage biomedical research and prompt an exodus of talent from the United States. Within hours, he had an email from China, offering to move his lab to 'any city, any university I want,' he said, with a guarantee of funding for the next 20 years. Dr. Patapoutian declined, because he loves his adopted country. Many scientists just setting out on their careers, however, fear there is no other option but to leave. Scientific leaders say that's risking the way American science has been done for years, and the pre-eminence of the United States in their fields. China and Europe are on hiring sprees. An analysis by the journal Nature captured the reversal: Applications from China and Europe for graduate student or postdoctoral positions in the United States have dropped sharply or dried up entirely since President Trump took office. The number of postdocs and graduate students in the United States applying for jobs abroad has spiked. A university in France that created new positions for scientists with canceled federal grants capped applications after overwhelming interest. A scientific institute in Portugal said job inquiries from junior faculty members in the United States are up tenfold over the last two months. 'We are embarking on a major experiment in restructuring the innovative engine in America, and China is the control,' said Marcia McNutt, a geophysicist and the president of the National Academy of Sciences, which was established by President Abraham Lincoln to advise the government on science policy. 'China is not going to cut its research budget in half.' Since the 1950s, when the federal government expanded the National Institutes of Health and created the National Science Foundation as public-private research partnerships, the United States has become the international mecca for science. It was the uniquely American system that President Franklin D. Roosevelt's science adviser, Vannevar Bush, envisioned in his landmark report, 'Science, The Endless Frontier': Federal money enabled scientific discoveries that made American research institutions the envy of the world, and they in turn fueled the rise of the United States as the leader in technology and biotechnology. As that system attracted international talent, it came to depend on the aspiring scientists who come to the United States to work in university labs at low wages for the privilege of proximity to the world's best researchers. They often stay: In the American defense industry and fields like engineering and computer and life sciences, at least half the workers with doctorates are foreign-born. Now, American science finds itself fighting on several fronts as the Trump administration seeks to cut budgets and seal borders, to punish universities for their liberalism and federal health agencies for their responses to Covid. Federal science budgets have been slashed. Stricter immigration policies have spread fear among international scientists working in the United States, and those who had hoped to. Graduate and postdoctoral students have had their visas canceled, or worry they will. The administration cut off funding for international students at Harvard — a judge blocked the move, but other universities worry about being next. Secretary of State Marco Rubio pledged to 'aggressively revoke' the visas of Chinese students in what he called 'critical fields,' which almost certainly includes science, where labs often have more Chinese than American-born graduate students and postdocs. President Trump has worried about the nation losing its scientific edge to 'rivals abroad,' as he wrote in a letter in March to his science adviser, Michael Kratsios. He urged Mr. Kratsios to continue Vannevar Bush's vision, 'recapturing the urgency which propelled us so far in the last century.' Yet Mr. Kratsios argues that philanthropies and industry should pick up more of the cost, and that too much federal science spending goes to bureaucracy. 'Spending more money on the wrong things is far worse than spending less money on the right things,' he said in a speech at the National Academy in May. But even at Johns Hopkins, which has benefited from the philanthropy of former New York Mayor Michael R. Bloomberg, those dollars can't make up the shortfall. Industry doesn't typically fund basic research, and it costs more to do research in industry in part because companies, unlike university labs, have to pay competitive wages. 'It's not just the international students, the whole system is on hold because the uncertainty does not allow you to plan,' Dr. Patapoutian said. 'With all these grants frozen or cut, it creates this massive chaos.' Just under half of the graduate students and postdocs in his lab hail from other countries. Now he is seeing less interest from abroad, but like many other lab heads he is not hiring new postdocs anyway: 'Everybody's kind of bolted down making sure we have the funds to keep the people we have.' In the first half of the 20th century, American scientists joined European universities to make fundamental discoveries: the structure of molecules (J. Robert Oppenheimer), the structure of DNA (James Watson). The rise of fascism in Europe drove many Jewish scientists to the United States. After World War II, 'we brought the rocket scientists here,' said Dr. McNutt. 'That's what got us to the moon.' While the logistics and expense of moving entire labs is likely to daunt more established researchers from moving, for postdocs and others just starting their labs, other countries offer the promise of greater stability. 'They are going to be able to recruit the best and brightest, proven people,' Dr. McNutt said. 'They are going to give them labs. They're going to give them equipment and funds, no questions asked.' At Johns Hopkins, which has long received more N.I.H. funding than any other university, Richard Huganir, the chairman of neuroscience, said he is 'terrified' of being unable to enroll international students. His department has 36 labs with 100 graduate students and postdocs, about 30 percent are international. 'For us, it would be losing 30 percent of our work force,' he said. 'They are integral to the whole fabric of American science, and losing that population would be devastating.' Graduate students and postdocs are going home to China and Korea for jobs, he said. Beyond losing talent, Dr. Huganir worries about the increasing isolation of American science. He canceled plans to host an international meeting at Hopkins because foreign scientists did not want to come to the United States; organizers considered moving it to Oxford, in England, but realized international students in the United States would not go because they fear not being allowed back in. Robert F. Kennedy Jr., the nation's top federal health official, this week said he wanted to bar scientists at the N.I.H. and other federal agencies from publishing in leading scientific journals, which he called 'corrupt.' Mathias Unberath, a computer scientist who studies computer-assisted medicine, came to Hopkins from Germany eight years ago. He has 13 doctoral students and two postdocs, all but five from abroad. 'My whole team, including those who were eager to apply for more permanent positions in the U.S., have no more interest,' he said. Those looking for jobs are applying in Europe, 'including some of my superstars,' he said. One American citizen, the recipient of a prestigious Siebel scholarship and an award for best paper, has taken a postdoc in Germany. Dr. Unberath himself was in the hospital with his wife, who had just given birth to their second son, when the first Trump administration suspended H-1B visas — Dr. Unberath had one. Now, he said, even if his students can get visas, they see the cuts to the N.S.F. and N.I.H. and worry they will not be able to get the early career grants they need to earn tenure. 'And if you don't make tenure,' he said, 'well, then what?' Daphne Koller came from Israel to do her Ph.D. in computer science at Stanford, became a professor there and was awarded a MacArthur Fellowship before founding two tech companies, Coursera, which puts university courses online, and Insitro, which uses artificial intelligence to drive drug discovery. Most of the first employees at both companies, she said, were hired right out of universities, and most were foreign-born. 'I would like nothing better than for the U.S. education system to really have the same emphasis on rigor and science and STEM so that we can train great scientists and engineers here,' Dr. Koller said. 'That would be incredible, but it doesn't happen magically. Even if that were ultimately the case, it's wonderful for a country to be in the unique position where it is the beacon, the magnet for the best and brightest from all over the world.' No institution has been more affected than Harvard, as the administration has made it an example of what it sees as the woke excesses of higher education. Rudolf Pisa, in a cell biology lab there, lost the N.I.H. grant that helps postdoctoral researchers transition to running their own labs. He came from the Czech Republic to do his Ph.D. at Rockefeller University in New York because he believed the American approach to science was 'brave.' His wife, a neuroscientist at Boston University, is American, but fears it is only a matter of time before her grant is canceled, too. They are looking for jobs in Europe. 'Two months ago I would not have thought of any of this,' Dr. Pisa said. He had considered himself a good investment for the United States. His work at Rockefeller helped lead to a patent and then a company to design cancer drugs that would be less likely to develop resistance over time. 'We created jobs,' he said. 'There's more out of it than just the papers.' The head of Dr. Pisa's lab, Tom Rapoport, said five of his students had their visas revoked before a judge temporarily restored them. He also lost the federal grant that funds his lab — despite a perfect score from N.I.H reviewers. He may have to reduce his lab from 14 people to eight, only one of them is American. Dr. Rapoport knows well how political turbulence affects science. His parents fled Nazism in Germany and Austria to train and work in the United States: His mother was a pediatrician, his father a biochemist who discovered how to prolong the shelf life of blood, which the U.S. military used to save countless service members. They left after being blacklisted as members of the Communist Party, ending up in East Germany. Dr. Rapoport was a professor there until the fall of the Berlin Wall; after, he had trouble getting a position, he said, because universities were suspicious of those from the East. He joined Harvard in 1995 because he admired the innovation and rigor of American science. 'This is scientific heaven,' he said. 'Or it used to be.' He worries that Americans don't appreciate how the system has worked for so long. 'Many people look at us as just parasites,' he said. 'All the medicines that people take, they were all developed in the U.S. There's essentially nothing developed by anyone else. We are on the top of the whole thing, and we're really risking it all.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store